Literature DB >> 29371059

COPD exacerbations in the emergency department: Epidemiology and related costs. A retrospective cohort multicentre study from the Italian Society of Emergency Medicine (SIMEU).

Federico Germini1, Giacomo Veronese2, Maura Marcucci3, Daniele Coen2, Deborah Ardemagni4, Nicola Montano5, Andrea Fabbri6.   

Abstract

Acute exacerbations of chronic obstructive pulmonary disease (AECOPDs) frequently cause patients with COPD to access the emergency department and have a negative impact on the course of the disease. The objectives of our study were: 1) describing the socio-demographic and clinical characteristics, and the clinical management, of patients with AECOPD, when they present to the emergency department; and 2) estimating the costs related to the management of these patients. We conducted a retrospective cohort study in Italy, collecting data on 4396 patients, from 34 centres. Patients had a mean (SD) age of 76,6 (10.6) years, and 61.2% of them where males. >70% of the patients had a moderate to very high comorbidity burden, and heart failure was present in 26.4% of the cohort. The 64.6% of patients were admitted to hospital wards, with a mean (SD) length of stay of 10.8 (9.8) days. The estimated cost per patient was 2617 €.
CONCLUSIONS: Patients attending the ED for an AECOPD are old and present important comorbidities. The rate of admission is high, and costs are remarkable.
Copyright © 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic obstructive Emergency service; Cost analysis; Hospital epidemiology costs; Pulmonary disease

Mesh:

Year:  2018        PMID: 29371059     DOI: 10.1016/j.ejim.2018.01.010

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  5 in total

1.  Ambient air particulate matter (PM10) satellite monitoring and respiratory health effects assessment.

Authors:  Mahssa Mohebbichamkhorami; Mohsen Arbabi; Mohsen Mirzaei; Ali Ahmadi; Mohammad Sadegh Hassanvand; Hamid Rouhi
Journal:  J Environ Health Sci Eng       Date:  2020-10-03

2.  Risk Factors for Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Industrial Regions of China: A Multicenter Cross-Sectional Study.

Authors:  Hongna Dong; Yuqiu Hao; Dapeng Li; Zhenzhong Su; Wei Li; Bingqing Shi; Peng Gao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-09-24

3.  The Impact of the Age, Dyspnoea, and Airflow Obstruction (ADO) Index on the Medical Burden of Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Chin-Ling Li; Mei-Hsin Lin; Yuh-Chyn Tsai; Ching-Wan Tseng; Chia-Ling Chang; Lien-Shi Shen; Ho-Chang Kuo; Shih-Feng Liu
Journal:  J Clin Med       Date:  2022-03-29       Impact factor: 4.241

Review 4.  Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds.

Authors:  Giulia Prinzi; Alessia Santoro; Palma Lamonaca; Vittorio Cardaci; Massimo Fini; Patrizia Russo
Journal:  Mar Drugs       Date:  2018-09-04       Impact factor: 5.118

5.  Jianpi Huatan Tongfu granule alleviates inflammation and improves intestinal flora in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Wenxing Yong; Liying Zhang; Yuexuan Chen; Juan Li; Yongqi Liu; Zhiming Zhang
Journal:  J Int Med Res       Date:  2020-04       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.